Safe S.A. specializes in the design, manufacture and marketing of medical devices for spine surgery. The company offers implants and instruments in the range of SteriSpine (the first spinal arthrodesis system that is for single use and is sterile and totally traceable). The group's activity is organized around 2 areas: - direct and indirect sales of medical devices (Safe Orthopaedics): business carried out in France, Germany, the United Kingdom, the United States and South America; - subcontracted manufacturing services for orthopedic medical devices (Safe Medical).

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company

Quotes

Date	Price	Change
26-09-30	€0.6400	-.--%
26-09-29	€0.6400	-.--%
26-09-28	€0.6400	-.--%
26-09-25	€0.6400	-.--%
26-09-24	€0.6400	-.--%

Real-time Euronext Paris

More quotes

Real-time Euronext Paris 11:55:00 2026-09-30 EDT			5-day change	1st Jan Change
0.6400 ^EUR	-.--%		-.--%	-63.43%

06-30	Safe Group sharply improves its full-year results
06-28	Safe Orthopaedics SA Reports Earnings Results for the Full Year Ended December 31, 2025	CI

Market Cap	128K 145K 121K 109K 206K 13.88M 208K 1.45M 556K 7.1M 544K 532K 22.76M	P/E 2024 *	-	P/E 2025	-0.07x
Enterprise Value	13.24M 15.03M 12.54M 11.32M 21.34M 1.44B 21.62M 150M 57.76M 737M 56.46M 55.22M 2.36B	EV / Sales 2024	2.39x	EV / Sales 2025	2.47x
Free-Float	87.27%	Yield 2024 *	-	Yield 2025	-

06-30	Safe Group sharply improves its full-year results
06-28	Safe Orthopaedics SA Reports Earnings Results for the Full Year Ended December 31, 2025	CI
05-28	Safe And ABL Alpstein Sign Exclusive Distribution Agreement For SteriSpine Range In Peru	CI
05-28	Safe Group enters Peru with exclusive distribution agreement
03-16	Changes to the SAFE Board of Directors
12-17	Safe Orthopaedics Signs Exclusive Distribution Agreement for Spanish Market	MT
12-17	Safe Group Signs Strategic Distribution Agreement in Spain with Vortrom Biologics	CI
11-30	Safe Orthopaedics SA Reports Earnings Results for the Full Year Ended December 31, 2024	CI
25-07-28	Alert wrongly tagged to Safe SA withdrawn	RE
24-12-27	Safe Orthopaedics SA Reports Earnings Results for the Half Year Ended June 30, 2024	CI
24-09-09	The market burns its idols
24-02-05	Safe: wins its appeal against Neo Medical
23-12-28	Safe: audit initiated for a turnaround plan

12-22	SAFE, SPONSOR OF THE 12TH MAMMI INTERNATIONAL CONFERENCE IN ITALY	GL
12-17	SAFE SIGNS A STRATEGIC DISTRIBUTION AGREEMENT IN SPAIN WITH VORTROM BIOLOGICS	GL
12-17	SAFE SIGNS A STRATEGIC DISTRIBUTION AGREEMENT IN SPAIN WITH VORTROM BIOLOGICS	AQ
24-09-09	New bond financing agreement in a minimum amount of €3 million in anticipation of validation of the continuation plan	GL
23-11-24	Safe group announces the convocation of the Annual General Meeting of Shareholders to be held on December 15th 2023 and provides an update on the situation	AQ

Safe S.A. Stock

Stocks

ALSAF

FR001400ZU25

Medical Equipment, Supplies & Distribution

Valuation: Safe S.A.

Chart: Safe S.A.

Latest news: Safe S.A.

Press Releases: Safe S.A.

News in other languages: Safe S.A.

Quotes and Performance

Price Extremes

Managers and Directors: Safe S.A.

Latest insider transactions

Medical Devices & Implants

Financials

Company Profile

Quotes

09-08	SAFE : point sur l'audience du 7 septembre 2026 devant le Tribunal des activités économiques de Lyon
08-25	SAFE Group : point sur la suspension de cotation et sur la certification des comptes annuels 2025
06-30	Safe Group améliore nettement ses résultats annuels
05-28	Safe Group s'implante au Pérou avec un accord de distribution exclusif
04-28	Safe S A : Report de la publication des résultats annuels 2025 de SAFE Group

1 week	0.64	0.64
1 month	0.64	0.64
Current year	0.54	1.81
1 year	0.54	2.6
3 years	0.54	141,014.1
5 years	0.54	4,967,249,950.33
10 years	0.54	10,000,000,000

Manager	Title	Age	Since
Nicolas Papillon CEO	Chief Executive Officer	46	-
Thomas Droulout CTO	Chief Tech/Sci/R&D Officer	50	2010-02-14
François-Henri Reynaud DFI	Director of Finance/CFO	-	2017-11-08

Director	Title	Age	Since
Thomas Droulout BRD	Director/Board Member	50	-
François-Henri Reynaud BRD	Director/Board Member	-	2019-11-25
Ismaël Nujurally BRD	Director/Board Member	69	2019-11-25

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SAFE S.A.	0.00%	0.00%	-73.33%	-100.00%	145K
ABBOTT LABORATORIES	-2.10%	-4.50%	-26.21%	+2.04%	171B
MEDTRONIC PLC	-0.92%	-3.37%	-9.40%	+10.12%	110B
STRYKER CORPORATION	-1.21%	+0.73%	-25.50%	+0.78%	106B
ESSILORLUXOTTICA	-0.96%	-0.35%	-47.92%	-11.89%	75.99B
CENCORA, INC.	-2.39%	-3.85%	-3.93%	+66.83%	57.3B
BECTON, DICKINSON AND COMPANY	-1.63%	-1.93%	-4.37%	-30.76%	48.76B
HOYA CORPORATION	+3.44%	+5.40%	+18.51%	+60.88%	50.19B
IDEXX LABORATORIES, INC.	-2.11%	+0.03%	-18.27%	+19.42%	41.14B
DEXCOM, INC.	-0.40%	-1.64%	+28.24%	-7.51%	32.56B
Average	-0.14%	-1.31%	-16.22%	+0.99%	69.3B
Weighted average by Cap.	-0.03%	-2.07%	-16.16%	+9.50%

	2024	2025
Net sales	5.04M 5.72M 4.78M 4.31M 8.13M 549M 8.23M 57.14M 21.99M 281M 21.5M 21.03M 900M	5.36M 6.09M 5.08M 4.59M 8.65M 584M 8.76M 60.81M 23.4M 299M 22.87M 22.37M 957M
Net income	-1.93B -2.19B -1.83B -1.65B -3.11B -210B -3.15B -21.87B -8.42B -107B -8.23B -8.05B -344B	-4.67M -5.31M -4.43M -4M -7.54M -509M -7.63M -52.98M -20.39M -260M -19.93M -19.5M -834M
Net Debt	11.47M 13.03M 10.87M 9.81M 18.49M 1.25B 18.73M 130M 50.04M 639M 48.91M 47.85M 2.05B	13.11M 14.89M 12.42M 11.22M 21.14M 1.43B 21.41M 149M 57.2M 730M 55.91M 54.69M 2.34B